Global Biochips Market Growth 2022-2028

Global Biochips Market Growth 2022-2028

Product Code:206604

Published Date: Jan 05,2022

Pages: 105

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

As the global economy mends, the 2021 growth of Biochips will have significant change from previous year. According to our (LP Information) latest study, the global Biochips market size is USD  million in 2022 from USD 9295.7 million in 2021, with a change of % between 2021 and 2022. The global Biochips market size will reach USD 17480 million in 2028, growing at a CAGR of 9.4% over the analysis period.

The United States Biochips market is expected at value of US$  million in 2021 and grow at approximately  % CAGR during review period. China constitutes a  % market for the global Biochips market, reaching US$  million by the year 2028. As for the Europe Biochips landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at  % and  % respectively for the next 5-year period.

Global main Biochips players cover Abbott, Agilent Technologies, Illumina, and PerkinElmer, etc. In terms of revenue, the global largest two companies occupy a share nearly  % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Biochips market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
    DNA Chip
    Lab-on-a-Chip
    Protein Chip
    Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
    Biotechnology and Pharmaceutical Companies
    Hospitals and Diagnostics Centers
    Academic & Research Institutes
    Other End Users

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
    Abbott
    Agilent Technologies
    Illumina
    PerkinElmer
    Thermo Fisher Scientific
    BioChain
    Bio-Rad Laboratories
    Cepheid
    EMD Millipore
    Fluidigm
    SuperBioChips Laboratories
    US Biomax
    Roche Diagnostics